Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis

J Neurol. 2022 Apr;269(4):1905-1912. doi: 10.1007/s00415-021-10754-9. Epub 2021 Aug 19.

Abstract

Axonal polyneuropathy is the main feature of hereditary transthyretin amyloidosis (ATTRv). Nerve morphological abnormalities have been reported, but longitudinal changes have never been assessed. We performed a prospective widespread nerve ultrasound evaluation and nerve cross-sectional area (CSA) was compared with baseline data in both ATTRv patients and pre-symptomatic carriers. Thirty-eight subjects were evaluated (mean follow-up 17.1 months), among them 21 had polyneuropathy while 17 were pre-symptomatic carriers. CSA significantly increased at brachial plexus in both groups (p = 0.008 and p = 0.012) pointing to progressive brachial plexus enlargement as a longitudinal biomarker of both disease progression and disease occurrence in pre-symptomatic carriers.

Keywords: Amyloidosis; Brachial plexus; Peripheral nerves; Transthyretin; Ultrasound.

MeSH terms

  • Amyloid Neuropathies, Familial* / complications
  • Amyloid Neuropathies, Familial* / diagnostic imaging
  • Biomarkers / analysis
  • Brachial Plexus* / diagnostic imaging
  • Disease Progression
  • Humans
  • Neurons / pathology
  • Polyneuropathies / complications
  • Prospective Studies

Substances

  • Biomarkers

Supplementary concepts

  • Amyloidosis, Hereditary, Transthyretin-Related